DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR MS Speaks
       *****************************************************
   DIR FDA fails to approve tolebrutinib for MS
       0 replies
   DIR Rituxan (rituximab)
       30 replies
   DIR FDA side effects update: New liver injury warnings for MS drug...
       0 replies
   DIR Chronic progressive MS market to witness accelerated expansion...
       0 replies
   DIR (Abst.) Moderate-high efficacy DMTs reduce relapse risk in lat...
       0 replies
   DIR Ibudilast receives fast track designation--studied for SPMS an...
       9 replies
   DIR (ECTRIMS) Novel drug shows hints of promise for progressive MS
       0 replies
   DIR (ECTRIMS preliminary abstract) Defining optimal profiles for t...
       0 replies
   DIR (Abst.) DMT efficacy and relapse severity in RRMS
       0 replies
   DIR (Abst.) Effectiveness of DMTs in patients with late-onset RRMS
       0 replies
       *****************************************************
   DIR Next Page